|
FY2025
12 months to Dec 27, 2025
|
FY2024
12 months to Dec 28, 2024
|
FY2023
12 months to Dec 30, 2023
|
FY2022
12 months to Dec 31, 2022
|
FY2021
12 months to Jan 1, 2022
|
|
|---|---|---|---|---|---|
| Net sales | |||||
| Cost of sales | |||||
| Gross profit | |||||
| Selling, general, and administrative expenses | |||||
| Research and development expenses | |||||
| Amortization of intangibles | |||||
| Restructuring, impairment, and other charges | |||||
| Total operating expenses | |||||
| Operating income | |||||
| Interest expense | |||||
| Foreign exchange loss (gain) | |||||
| Other income, net | |||||
| Income before income taxes | |||||
| Income taxes | |||||
| Net (loss) income | |||||
| (Loss) income per share: | |||||
| Basic (in dollars per share) | |||||
| Diluted (in dollars per share) | |||||
| Weighted average shares and equivalent shares outstanding: | |||||
| Basic (in shares) | |||||
| Diluted (in shares) | |||||
Loading...
